The Norwegian royal court announced on Tuesday that Crown Princess Mette-Marit’s health has worsened. She suffers from pulmonary fibrosis, a chronic lung disease that was first reported by the royal court in October 2018. At that time, the court revealed that she had been diagnosed with a chronic lung condition that could affect her ability to fulfill her royal duties, although the specific nature of the disease was not initially clear.

Subsequent information confirmed that Mette-Marit is dealing with pulmonary fibrosis, an incurable illness where lung tissue becomes scarred. This scarring impedes the exchange of oxygen and carbon dioxide within the body. Symptoms include persistent dry cough and shortness of breath, which have escalated over time despite the condition being identified relatively early. The initial assessment by medical professionals indicated that the disease was not caused by environmental factors or lifestyle, suggesting that her condition may have been hereditary or of unknown origin.

The implications of Crown Princess Mette-Marit’s deteriorating health are multifaceted, affecting not only her personal well-being but also her public role as a member of the royal family. As she continues to address her health challenges, there may be increasing challenges in performing the responsibilities expected of her within the royal family. Public interest and concern for her health are likely to continue as updates from the royal court supply new insights into her condition and its impact on her life and duties.